Executing with balance and focus to deliver growth and create value
We are a global leader in Sample to Insight solutions, with a portfolio of technologies to empower customers from start to finish in the molecular analysis process. In a challenging world, our approach is to help customers achieve molecular insights faster, better and more efficiently.
Our strategy contains a focus on 5 Pillars of Growth where we have novel technologies targeting >$6 billion in opportunities out of our >$11 billion total addressable market. In these areas we are aligning our investments to maximize sales in proven high-growth markets. (See the Key product areas section on Our Products page for more details)
Our business is well-balanced across the globe (see Our global presence for more details) over two major customer classes. We have built a unique competitive advantage for QIAGEN: deep relationships with customers across the continuum from academic research, to pharmaceutical development, to molecular diagnostics and other applications. We partner with researchers in creating molecular testing technologies in the early stages, then develop and commercialize promising applications and platforms as these methods emerge in healthcare and industry.